These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 28796092)
1. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats. Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092 [TBL] [Abstract][Full Text] [Related]
2. SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours. Petremann M; Romanet C; Broussy A; Van Ba CT; Poli S; Dyhrfjeld-Johnsen J Otol Neurotol; 2019 Feb; 40(2):254-263. PubMed ID: 30570608 [TBL] [Abstract][Full Text] [Related]
3. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss. Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions. Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A Audiology; 2001; 40(5):253-64. PubMed ID: 11688544 [TBL] [Abstract][Full Text] [Related]
5. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Choe WT; Chinosornvatana N; Chang KW Otol Neurotol; 2004 Nov; 25(6):910-5. PubMed ID: 15547419 [TBL] [Abstract][Full Text] [Related]
6. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss. Bielefeld EC Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622 [TBL] [Abstract][Full Text] [Related]
7. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity. Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy. Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784 [TBL] [Abstract][Full Text] [Related]
9. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression. Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210 [TBL] [Abstract][Full Text] [Related]
11. Noise-induced threshold shift dynamics measured with distortion-product otoacoustic emissions and auditory evoked potentials in chinchillas with inner hair cell deficient cochleas. Hamernik RP; Ahroon WA; Jock BM; Bennett JA Hear Res; 1998 Apr; 118(1-2):73-82. PubMed ID: 9606062 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model. Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489 [TBL] [Abstract][Full Text] [Related]
13. Lovastatin protects against cisplatin-induced hearing loss in mice. Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294 [TBL] [Abstract][Full Text] [Related]
14. Effects of ozone (O Koçak HE; Taşkın Ü; Aydın S; Oktay MF; Altınay S; Çelik DS; Yücebaş K; Altaş B Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387 [TBL] [Abstract][Full Text] [Related]
15. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin alleviates cisplatin-induced ototoxicity in vivo. Fang B; Xiao H Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670 [TBL] [Abstract][Full Text] [Related]
17. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity. Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780 [TBL] [Abstract][Full Text] [Related]
18. Light microscopy study of cisplatin-induced ototoxicity in rats. de Freitas MR; de Castro Brito GA; de Carvalho JV; Gomes RM; Barreto Martins MJ; de Albuquerque Ribeiro R J Laryngol Otol; 2009 Jun; 123(6):590-7. PubMed ID: 19144244 [TBL] [Abstract][Full Text] [Related]
19. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model. Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model. Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]